“…Moreover, in combination with 5-fluorouracil, OMT can produce a synergistic anti-tumor effect both in vitro and in vivo [55]. Several recent studies have demonstrated the anticancer effects of OMT in diverse cancer cell lines such as prostate cancer [56], ovarian cancer [57], gastric cancer [58], colorectal cancer [59,60,61], breast cancer [62,63], bladder cancer [64], hepatocellular carcinoma [55], esophageal carcinoma [65], osteosarcoma [66,67], cervical cancer [68,69], gallbladder carcinoma [70], laryngeal carcinoma [71], hemangioma [72], lung cancer [73,74,75,76], synovial sarcoma [77], glioblastoma [78,79], and nasopharyngeal carcinoma [80]. The molecular mechanism(s) of action of OMT was found to be mediated by inducing cell cycle arrest and apoptosis and by causing an inhibition of angiogenesis and metastasis [57,64,81,82].…”